bioRxiv / medRxivopen access
Safety and Biological Activity of Intravitreal OGX110, a CXCR3 Agonist, in Persistent Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study
ophthalmology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 319799
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.